SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Action Pharma Initiates Phase IIb Clinical Trial in the USA And Denmark With AP214 to Prevent Kidney Injury Associated With Major Cardiac Surgery